Perioperative methadone compared to placebo in elderly hip fracture patients: a study protocol for a randomized controlled trial (MetaHip trial)
2024

Methadone vs Placebo for Pain Management in Elderly Hip Fracture Patients

Sample size: 130 publication Evidence: moderate

Author Information

Author(s): Kevin Heebøll Nygaard, Thomas Strøm, Kirsten Specht, Sofie Ronja Petersen, Jesper Ougaard Schønnemann

Primary Institution: University Hospital of Southern Denmark

Hypothesis

The utilization of a single dose of perioperative methadone may lead to a reduction in pain severity and opioid consumption in elderly hip fracture patients.

Conclusion

If statistically significant advantages are found in the treatment group, perioperative methadone could enhance pain management for hip fracture patients.

Supporting Evidence

  • Previous studies suggest methadone may reduce opioid consumption and improve pain control.
  • The pilot study indicated a safe dose of 0.10 mg/kg for elderly patients.
  • Research in Europe on methadone's role in perioperative care is limited.

Takeaway

This study is testing if giving elderly patients methadone during hip surgery can help them feel less pain and need fewer painkillers afterward.

Methodology

A double-blinded randomized controlled trial comparing methadone to a saline placebo in patients aged 60 and older undergoing hip fracture surgery.

Potential Biases

Potential bias in patient selection and reporting of outcomes due to the subjective nature of pain assessment.

Limitations

The study may not account for all variables affecting pain management and recovery in elderly patients.

Participant Demographics

Patients aged 60 years and older with acute hip fractures.

Digital Object Identifier (DOI)

10.1186/s13063-024-08694-6

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication